Effect of growth hormone treatment in patients with chronic fatigue syndrome: A preliminary study

Growth Hormone and IGF Research

Volumn 8, Issue SUPPL. 2, 1998, Pages 131-133

  Moorkens, G ^a   Wynants, H ^a   Abs, R ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Body composition; Chronic fatigue syndrome; GH therapy; IGF I

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN C;

ADULT; BODY COMPOSITION; BODY MASS; BODY WATER; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032463324     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1096-6374(98)80037-3     Document Type: Article

References (7)

1. Bearn J, Allain T, Coskeran P et al. Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome. Biol Psychiatry 1995; 37: 245-252.
2. Demitrack MA, Dale JK, Strauss SE et al. Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome. J Clin Endocrinol Metab 1991; 73: 1224-1234.
3. Allain TJ, Bearn JA, Coskeran P et al. Changes in growth hormone, insulin, insulin-like growth factors and IGF-binding protein-1 in chronic fatigue syndrome. Biol Psychiatry 1997; 41: 567-573.
4. Burman P, Broman JE, Hetta J et al. Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab 1995; 80: 3585-3590.
5. Hew FL, Koschmann M, Christopher M et al. Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity. J Clin Endocrinol Metab 1996; 81: 555-564.
6. Cooper JDH, Turnell DC, Green B. Automated sequential trace enrichment of dialysates and robotics. J Chromatogr 1988; 456: 53-69.
7. Weaver JU, Monson JP, Noonan K et al. The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. J Clin Endocrinol Metab 1995; 80: 153-159.